Market Closed -
Toronto S.E.
04:00:00 2024-05-13 pm EDT
|
5-day change
|
1st Jan Change
|
38.88
CAD
|
-1.67%
|
|
-3.55%
|
-5.12%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
753.9
|
1,539
|
2,244
|
1,982
|
1,703
|
1,607
|
-
|
-
|
Enterprise Value (EV)
1 |
852.4
|
1,639
|
2,406
|
2,079
|
1,771
|
1,597
|
1,502
|
1,422
|
P/E ratio
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Yield
|
-
|
0.51%
|
0.37%
|
0.55%
|
0.83%
|
1.02%
|
1.29%
|
1.49%
|
Capitalization / Revenue
|
2.6
x
|
4.9
x
|
5.1
x
|
3.06
x
|
2.63
x
|
2.4
x
|
2.26
x
|
2.22
x
|
EV / Revenue
|
2.94
x
|
5.21
x
|
5.47
x
|
3.21
x
|
2.73
x
|
2.38
x
|
2.12
x
|
1.97
x
|
EV / EBITDA
|
12.1
x
|
20.8
x
|
20.2
x
|
11.9
x
|
10.8
x
|
9.52
x
|
8.15
x
|
7.68
x
|
EV / FCF
|
15.5
x
|
35.6
x
|
31.6
x
|
18.7
x
|
21.9
x
|
16.2
x
|
14.3
x
|
11.2
x
|
FCF Yield
|
6.46%
|
2.81%
|
3.16%
|
5.36%
|
4.57%
|
6.18%
|
7.01%
|
8.91%
|
Price to Book
|
12.3
x
|
17.2
x
|
6.39
x
|
4.5
x
|
3.62
x
|
3.09
x
|
2.79
x
|
2.52
x
|
Nbr of stocks (in thousands)
|
37,600
|
37,600
|
41,529
|
41,857
|
41,552
|
41,324
|
-
|
-
|
Reference price
2 |
20.05
|
40.94
|
54.03
|
47.35
|
40.98
|
38.88
|
38.88
|
38.88
|
Announcement Date
|
3/12/20
|
2/24/21
|
3/2/22
|
3/2/23
|
3/5/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
290
|
314.3
|
440.1
|
648.4
|
648
|
670.1
|
709.6
|
722.7
|
EBITDA
1 |
70.55
|
78.91
|
119.3
|
174.5
|
163.8
|
167.7
|
184.2
|
185.1
|
EBIT
1 |
44.99
|
50.94
|
73.7
|
110.3
|
96.05
|
96.66
|
111.6
|
110.9
|
Operating Margin
|
15.52%
|
16.21%
|
16.75%
|
17.02%
|
14.82%
|
14.42%
|
15.73%
|
15.35%
|
Earnings before Tax (EBT)
|
42.35
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
29.77
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
10.27%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
55.07
|
46.04
|
76.06
|
111.4
|
80.9
|
98.67
|
105.3
|
126.7
|
FCF margin
|
18.99%
|
14.65%
|
17.28%
|
17.18%
|
12.48%
|
14.72%
|
14.84%
|
17.53%
|
FCF Conversion (EBITDA)
|
78.05%
|
58.34%
|
63.78%
|
63.84%
|
49.39%
|
58.85%
|
57.17%
|
68.48%
|
FCF Conversion (Net income)
|
184.95%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.2100
|
0.2000
|
0.2600
|
0.3400
|
0.3950
|
0.5000
|
0.5800
|
Announcement Date
|
3/12/20
|
2/24/21
|
3/2/22
|
3/2/23
|
3/5/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
133
|
148.4
|
169.4
|
164.9
|
165.8
|
164.8
|
157.4
|
156.8
|
169.1
|
161.1
|
167.6
|
167.5
|
174.7
|
180.9
|
175.6
|
EBITDA
1 |
35.77
|
39.39
|
46.33
|
44.07
|
44.68
|
40.47
|
39.54
|
39.01
|
44.77
|
39.59
|
41.96
|
42.21
|
44.22
|
45.46
|
45.55
|
EBIT
1 |
21.45
|
24.16
|
30.16
|
27.86
|
28.17
|
23.69
|
22.6
|
21.72
|
28.04
|
21.24
|
25.07
|
25.39
|
26.92
|
30.19
|
29.61
|
Operating Margin
|
16.13%
|
16.29%
|
17.8%
|
16.9%
|
16.99%
|
14.38%
|
14.36%
|
13.86%
|
16.59%
|
13.18%
|
14.96%
|
15.16%
|
15.41%
|
16.68%
|
16.87%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0500
|
0.0600
|
0.0600
|
0.0700
|
0.0700
|
0.0800
|
0.0800
|
0.0900
|
0.0900
|
-
|
0.1000
|
0.1100
|
0.1100
|
-
|
-
|
Announcement Date
|
3/2/22
|
5/4/22
|
8/9/22
|
11/8/22
|
3/2/23
|
5/3/23
|
8/1/23
|
11/2/23
|
3/5/24
|
5/2/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
98.5
|
99.5
|
162
|
97.4
|
68.2
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
10
|
105
|
185
|
Leverage (Debt/EBITDA)
|
1.396
x
|
1.26
x
|
1.361
x
|
0.5584
x
|
0.4161
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
55.1
|
46
|
76.1
|
111
|
80.9
|
98.7
|
105
|
127
|
ROE (net income / shareholders' equity)
|
26.4%
|
49.4%
|
26.2%
|
19.2%
|
14.5%
|
13.8%
|
15%
|
-
|
ROA (Net income/ Total Assets)
|
12.2%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
|
244.8
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
1.640
|
2.370
|
8.450
|
10.50
|
11.30
|
12.60
|
13.90
|
15.40
|
Cash Flow per Share
2 |
-
|
1.330
|
2.100
|
3.210
|
2.450
|
2.950
|
3.020
|
-
|
Capex
1 |
5.94
|
4.97
|
8.03
|
25.7
|
23.5
|
24.5
|
23.8
|
22
|
Capex / Sales
|
2.05%
|
1.58%
|
1.82%
|
3.97%
|
3.63%
|
3.66%
|
3.35%
|
3.04%
|
Announcement Date
|
3/12/20
|
2/24/21
|
3/2/22
|
3/2/23
|
3/5/24
|
-
|
-
|
-
|
Last Close Price
38.88
CAD Average target price
49.71
CAD Spread / Average Target +27.87% Consensus |
1st Jan change
|
Capi.
|
---|
| -5.12% | 1.2B | | +17.18% | 85.55B | | -28.48% | 70.07B | | +6.76% | 28.95B | | -7.44% | 17.51B | | +2.14% | 17.39B | | +2.10% | 15.38B | | +7.02% | 13.4B | | +64.96% | 12.93B | | +6.64% | 12.77B |
Other Healthcare Facilities & Services
|